Neural network analysis was applied for early diagnosis/exclusion of acute myocardial infarction (AMI), prediction of infarct size, and estimation of "time from onset of infarction." Eighty-eight patients admitted within 8 h after onset of chest pain were included. Blood samples for measurement of myoglobin, creatine kinase isoform MB, and troponin T were obtained every 30 min during the first 3 h and then after successively longer intervals. Data from 50 patients were used to train a set of neural network components of a decision support system. The performance of the system was evaluated and compared with experienced clinicians for the remaining 38 patients. The computer system detected myocardial infarction and predicted infarct size earlier than the clinicians, but did not differ significantly in terms of diagnostic sensitivity, specificity, and predictive values when disregarding time for diagnosis. With a cross-validation procedure the cumulated sensitivities of the computer system for the first five measurements were estimated to be (mean ؎ 
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Neural network analysis was applied for early diagnosis/exclusion of acute myocardial infarction (AMI), prediction of infarct size, and estimation of "time from onset of infarction." Eighty-eight patients admitted within 8 h after onset of chest pain were included. Blood samples for measurement of myoglobin, creatine kinase isoform MB, and troponin T were obtained every 30 min during the first 3 h and then after successively longer intervals. Data from 50 patients were used to train a set of neural network components of a decision support system. The performance of the system was evaluated and compared with experienced clinicians for the remaining 38 patients. The computer system detected myocardial infarction and predicted infarct size earlier than the clinicians, but did not differ significantly in terms of diagnostic sensitivity, specificity, and predictive values when disregarding time for diagnosis. With a cross-validation procedure the cumulated sensitivities of the computer system for the first five measurements were estimated to be (mean ؎ An early diagnosis within the first hours after onset of symptoms is essential for the appropriate handling and optimal treatment of patients admitted with chest pain of suspected cardiac origin [1, 2] . The 12-lead electrocardiogram (ECG) is usually immediately available, and in cases with typical ST-segment elevations the diagnosis of acute myocardial infarction (AMI) is straightforward. 2 However, in the vast majority of patients with chest pain the 12-lead ECG is nondiagnostic on admission. In these patients ruling in and ruling out the diagnosis of AMI must be on the basis of repeated measurements of biochemical markers, currently a time-consuming procedure. Therefore, in recent years much interest has been focused on new biochemical markers for early rule-in and rule-out of AMI [3, 4] . Although the diagnostic sensitivity and specificity for AMI are generally high for these markers [5] [6] [7] [8] , they are not sensitive enough for ruling out AMI immediately upon admission [9] . In the heterogeneous group of patients with chest pain, considerable economic resources might be saved by early identification of those patients (ϳ60 -70%) who are at sufficiently low risk of AMI and its complications to be transferred to a general ward outside the coronary care unit (CCU) [3] .
Several different methods have been proposed to achieve some of these goals, including diagnostic algorithms based on clinical data [10, 11] or biochemical markers [12, 13] . The use of artificial neural networks is an alternative technique that has been applied for AMI diagnosis based on clinical data including ECG [14, 15] and biochemical markers [16, 17] . Artificial neural networks can be used to classify input patterns of measured variables as belonging to one of several predefined categories by pattern recognition. This is achieved by "training" of the network with a number of representative example cases and their corresponding correct classifications as defined by a gold standard. The network will correctly classify a major portion of the patterns in this training set by a procedure in which the parameters of the network (the connection weights and biases) are adjusted to minimize a cost function measuring the difference between the network's classification and the gold standard (so-called "supervised learning"). When exposed to a new, not yet classified case, the network uses its previous training and its capability of generalization for assignment to a specific diagnostic category. For further reading see ref.
18.
The aim of the present investigation was to apply artificial neural network methods, based on frequent sampling and measurement of selected markers of AMI, for (a) early diagnosis or exclusion of AMI, (b) early prediction of infarct size, (c) estimation of time from onset of infarction, and (d) to compare the performance of the neural networks with experienced physicians.
Materials and Methods patients
The present study was part of a Swedish multicenter study (BIOMACS) [13] . Included in the present analysis were all patients admitted to the participating CCUs with chest pain, and with onset within the previous 8 h and, in case of AMI, not given thrombolytic treatment; in total, 88 patients. The study was approved by the local ethics committees, and all enrolled patients provided informed consent.
laboratory investigations
Standard 12-lead ECGs were recorded on admission and after 24 and 48 h. Blood samples were drawn from an indwelling forearm venous catheter, the first sample on admission and thereafter every 30 min during the first 3 h and then at 4, 6, 9, 12, 18, 24, and 48 h after admission. The mass concentration of creatine kinase isoenzyme MB (CK-MB) in plasma was measured with the NovoClone system (Novo BioLabs) [19] ; the upper reference limit for healthy individuals is 7 g/L and the total analytical CV was estimated to be 8.4% at a concentration of 25 g/L (n ϭ 154). The plasma myoglobin mass concentration was determined with a modified RIA method developed by Roxin et al. [20] . The upper reference limits are 57 g/L for women and 90 g/L for men. The total analytical CV for this modified method was 6.1% at a concentration of 61 g/L (n ϭ 49). The mass concentration of troponin T (Tn-T) in plasma was determined with the Enzymun-Test system (Boehringer Mannheim) [21] . The total analytical CV was estimated to 6.3% at a concentration of 3.8 g/L (n ϭ 56). All plasma samples and ECGs were centrally analyzed and interpreted, without knowledge of the patients' diagnoses or outcomes.
gold standard
AMI was considered present if at least two of the three WHO criteria were fulfilled [22] . The infarct size was arbitrarily labeled "major" if the peak plasma CK-MB mass concentration was Ͼ80 g/L and "minor" if peak CK-MB mass concentration was Յ80 g/L.
computational methodology
The system was designed to select neural network architectures of minimal complexity. A balanced version of the cross-validation method (cf. [23, 24] ) was used to select an adequate neural network for each classification problem: Data from all 88 patients were randomly partitioned into a training set (67%) and a cross-validation set (33%) with realistic prevalences of major AMI, minor AMI, and non-AMI in the two sets. The procedure was repeated 20 -100 times for each architecture and the mean and standard error (SEM) of diagnostic sensitivity, specificity, and positive and negative predictive values were calculated. Each candidate neural network was trained and evaluated on these sets.
The measured values of the biochemical markers were normalized by division with the respective upper reference limits to facilitate transferability of the method. The values were further fuzzified with piecewise linear membership functions selected individually for the input variables to achieve as good univariate separation as possible between the diagnostic classes in the training set. The membership functions were characterized by two parameters, c min and c max , transforming normalized values lower than c min to 0, higher values than c max to 1, and linearly increasing values from 0 to 1 in the interval (c min ; c max ). This type of preprocessing makes it possible to perform nonlinear classification with simple single-layer perceptrons (cf. [25] ), the basic functional unit of a neural network. Neural network architectures of diverse complexity [single-layer perceptrons (SLPs) and multi-SLPs with fuzzified input variables, multilayer perceptrons (MLP) with 2 and 3 hidden units, and Elman recurrent networks 3 with 2 and 10 feedback units] were evaluated. The preprocessed measured values of the infarct markers (myoglobin, CK-MB, and Tn-T) and in some cases also their respective rate of change, expressed as the difference ⌬ to previous value, were used as input variables. The number of markers was also varied to find the optimum set of input variables. The SLPs and the MLPs all used sigmoidal transfer functions and were trained with the Levenberg-Marquardt method to minimize a cost function (sum of squared residuals) as implemented in the Neural Network Toolbox 2.0 (The Mathworks). Recognizing that the phenomenon known as "overtraining" does not occur in models of sufficiently low complexity (cf. [24] ), the SLPs were trained until the training set was classified with a minimum error. The training of the MLPs was stopped, to avoid overtraining, when the performance of the networks was optimal, as measured by the objective function of the sum of squared residuals on the cross-validation set used as a validation set 4 . In this case the performance of the MLPs thus approximates an upper bound of what is attainable with the technique of "early stopping" for maximizing generalization. The back-propagation algorithm (in the Neural Network Toolbox 2.0) was used for training the Elman recurrent networks. The conventional method for early stopping, with a validation set during training for monitoring of the generalizing capability of the network, was not necessary because the performance on the cross-validation sets (used as validation sets) measured by the sum of squared residuals generally settled at a constant concentration after the training set was classified with a minimum error. Thus, the Elman networks as used in this application were considered not to be overtrained.
To meet the requirement of early detection of AMI, the candidate neural networks were tuned with ROC curve analysis to rule in all AMI patients within 2 h (five sets of measurements) after admission. The preferred neural network architecture was selected by comparing the respective cumulated sensitivity and specificity of the candidate networks for each consecutive set of measurements (#1-5). The preferred neural networks for prediction of infarct size and estimation of time from onset, respectively, were selected on the basis of highest sensitivity at comparable specificities (Ͼ0.80) with ROC curve analysis.
The selected neural networks and sets of input variables for the various classification problems are summarized in Table 1 . Tn-T did not contribute significantly to the diagnostic performance of the neural network classifiers and was therefore excluded from the list of input variables. Three SLPs were used in parallel (multi-SLP) for classification of AMI/non-AMI; each SLP was individually trained to detect AMI on the basis of measurements from a specified time interval (Ͻ6 h; 6-8 h; Ͼ8 h) since onset of infarction, thus making it possible to handle the nonlinearity due to the pronounced temporal variation in concentrations of the selected biochemical markers. If the output from any one of the individual SLPs should indicate an AMI, that was taken to be the actual state. If AMI was not detected after a predefined optimal period of monitoring (2 h or five sets of measurements), AMI was excluded. Prediction of infarct size was performed with a SLP without fuzzification (identical to logistic regression). Estimation of the "time from onset," performed when AMI was diagnosed, involves a SLP with fuzzification and 3 output units trained to indicate whether the onset occurred before a specified number of hours after infarction (Յ5 h; Յ6 h; Յ7 h). The training and the crossvalidation sets were both extended in this case; all sets of measurements from patients correctly classified as AMI and measured within 12 h from onset of infarction were included. The predictive values were calculated according to realistic prevalences from the Uppsala University Hospital/CCU database.
methods for comparison with clinicians
For comparing the performance of the computer method with the clinicians, the 88 patients were divided into one "training set" of 50 patients and one "test set" of 38 patients. These two sets are presented in Table 2 . The characteristics of the AMI patients are further detailed in Table 3 . The relative numbers of AMI and non-AMI in the test set are fairly close to the corresponding figures of 22% and 78% calculated from the Uppsala University Hospital/CCU database (RiksHIA) for the same category of patients admitted to the CCU during 1994 (with arrival Ͻ8 h after onset of symptoms and without thrombolytic therapy). Three clinicians with several years of experience of working in the emergency department and the CCU were presented with the series of measured values of biochemical markers in time order by using a computer. They were asked to classify the patients as AMI or non-AMI and to predict the infarct size. To make the evaluation clinically relevant, the clinicians also had access to the 12-lead ECG on admission, in parameterized form, as well as the time from onset of symptoms, age, and sex. By following this procedure, the assessments put forward by the clinicians could be compared with the assessment by the computer method in terms of conventional measures of diagnostic performance.
methods for comparison with empirical rules for rule-in/-out of ami
The performance of the computer method was also compared with the empirical rules proposed in a previous report from the BIOMACS study [13] ; one rule for the early assessment of AMI: plasma CK-MB Ն20 g/L or myoglobin above the upper reference limit and CK-MB Ն10 g; a second rule for exclusion of AMI 3 h after admission: no sample of myoglobin above the upper reference limit; and a third rule for the exclusion of AMI 6 h after admission: no sample of CK-MB Ն8 g/L.
Results

comparison with clinicians
In the test set of 38 patients, the computer method detected AMI earlier than the clinicians; AMI was correctly detected on the first measurement in 90% of the cases, compared with 70% for the clinicians. For the remaining cases, the computer system required one more measurement (additional 30 min) for correct diagnosis, and the clinicians required on average two more measurements (additional 60 min). Sensitivity, specificity, and predictive values for detection of AMI were high and not significantly different for the computer method and the clinicians when disregarding the time for diagnosis ( Table 4 ).
The rate of correctly ruled-in AMI patients, estimated by the cross-validation procedure and expressed as cumulated sensitivity Ϯ 2SEM (n ϭ 100), was 0.77 Ϯ 0.03, 0.89 Ϯ 0.02, 0.94 Ϯ 0.02, 0.97 Ϯ 0.01, and 0.99 Ϯ 0.01 for the first five measurements, respectively, with a corresponding cumulated specificity between 0.93 Ϯ 0.01 and 0.91 Ϯ 0.01.
For exclusion of AMI, the computer method was optimized to use a fixed number of five measurements. The clinicians required five measurements on average but with a large variation (1-10 sets of measurements).
The computer method made a correct prediction of infarct size earlier than the clinicians (Table 5 ). The computer method and the clinicians did not differ significantly (considering the low number of test cases) in terms of diagnostic sensitivity, specificity, and positive and negative predictive values (Table 6 ).
comparison with empirical rules for rule-in/-out of ami
The empirical rules, when applied to the test set, required more measurements than the computer method to rule in AMI. On admission, 80% of the cases were correctly detected. The remaining cases needed two more measurements on average. At 3 h after admission, the empirical rules had correctly ruled out 63% of the patients with Hours since onset of chest pain until first blood sample Diagnostic sensitivity, specificity, and positive and negative predictive values for assessment of AMI by the computer method and the clinicians on the test set of 38 patients. Results are expressed as mean and range (in parentheses). Mean time delay, expressed in number of measurements and minutes since the start of measurement, until a correct prediction of infarct size (major AMI or minor AMI) was achieved by the computer method and the clinicians on the 11 AMI patients in the test set. Turnaround time for laboratory analysis is not included. Results are expressed as mean and range (in parentheses).
non-AMI in the test set, 26% had an uncertain diagnosis, and the remaining 11% were incorrectly classified as AMI in the previous step. The same figures for the computer system 2 h after admission were 93%, 0%, and 7%, respectively. At 6 h after admission, the empirical rules had correctly ruled out 85% of the patients with non-AMI, which was in parity with the computer method 4 h earlier.
estimation of time from onset of infarction
The performance of the computer method for diagnostic sensitivity, specificity, and predictive values is presented in Table 7 .
Discussion
A computational method based on several individually trained artificial neural networks was developed and validated on a clinically relevant reference sample group of patients with suspected AMI. Our results indicate that by using repeated blood sampling and analyses of plasma myoglobin and CK-MB mass concentration during the first hours after admission it is possible for the computer method not only to reliably diagnose AMI and predict infarct size, but also to crudely estimate the time from onset of infarction. Not surprisingly, Tn-T measurements were found not to add to the diagnostic performance of networks for early detection/exclusion of AMI, considering the similar or slightly slower appearance of Tn-T compared with CK-MB in plasma during the first 8 h. In this context, early Tn-T measurements are of potential value for indication of old infarctions. Currently, its most important role seems to be as a risk indicator of subsequent cardiac events in patients with unstable coronary artery disease [27] . The patients in the test set were generally correctly classified with regard to AMI and non-AMI, both by the computer method and the clinicians. The major difference in performance was in the time required to make a correct diagnosis. The mean time was shorter and the variation smaller for the computer. In comparison with an application of empirical rules based on plasma myoglobin and CK-MB measurements [13] , the neural network method was faster both for detection and particularly for exclusion of AMI. This comparison is biased in favor of the empirical rules, since they were derived with the whole material (including the patients in the test set). Performed very early, a crude prediction of the impending infarct size might be of value for the clinician in deciding whether to use infarct-limiting therapy (i.e., thrombolysis or acute percutaneous transluminal coronary angioplasty). To achieve this, the computer system was designed to perform the size prediction, requiring at most one more set of measurements after the detection of AMI. The computer system predicted infarct size approximately on the second measurement, and 10 of 11 AMI patients were predicted correctly by the system. In contrast, the clinicians required considerably longer time than the computer system for predicting infarct sizes, four and six sets of measurements on average for classification of major and minor infarctions, respectively. Examples of the time curves for the biochemical markers and time points when AMI was detected and size was predicted by the computer and the three clinicians are shown in Fig. 1 . These results indicate that a correct early infarct size prediction, although crude, is feasible with the computer method suggested.
Some patients have difficulties in stating the time for onset of chest pain, and furthermore, the onset of chest pain might be an uncertain estimate for onset of infarction in the individual patient [28] . Therefore, a "second opinion" from the computer, based on the pattern of biochemical markers, might be of value, e.g., for the decision to give or not to give the patient thrombolytic treatment. The results indicate that it might be possible to make an interval estimate of the time from onset of infarction very early with reasonable certainty.
Although thrombolytic treatment is only proven to be beneficial for patients with ST elevation or bundle branch block in the ECG on admission [29] , it might well also be of benefit in certain subgroups of patients with nondiagnostic ECGs [30] , e.g., patients with short delay and an impending large infarction. Given the possibility to select such subgroups, e.g., with the use of neural network methods, elucidating the value of thrombolysis in these subgroups will be an important area of research [31] .
Although the patient material was representative for a CCU population and unique with the early frequent blood sampling, the number of patients was limited in Diagnostic sensitivity, specificity, and positive and negative predictive values for prediction of major infarct size (major/minor) by the computer method and by clinicians. Range is given in parentheses. Table 7 . Statistical measures of diagnostic performance regarding assessment of time from onset. Clinical Chemistry 43, No. 10, 1997 both the test and training sets. Therefore, the results must be regarded as indicative of the potential benefit of a neural network-based computer system in the early assessment of patients with acute chest pain. Further studies in larger groups of patients are needed. Time points are marked with arrows when the computer and the three clinicians detected the infarction and predicted the infarct size. s, myoglobin; F, CK-MB; ‚, Tn-T. Relative concentration ϭ plasma concentration (g/L) divided by 90/57 g/L (men/women) and 7 g/L for myoglobin and CK-MB, respectively. For Tn-T a decision limit of 0.2 g/L was used, in lack of an established upper reference limit for healthy individuals at the time of this study.
Measures of diagnostic performance
